Phage Display Libraries for Antibody Therapeutic Discovery and Development

Area of Science:

• Biotechnology
• Immunology
• Drug Discovery

Background:

• Phage display technology, pioneered in the 1980s and applied to antibody engineering in the 1990s, is crucial for antibody discovery and optimization.
• It has significantly advanced the development of antibody-based therapeutics.
• This review focuses on state-of-the-art phage display antibody libraries.

Purpose of the Study:

• To compare nine recent phage display antibody libraries.
• To assess library quality, repertoire diversity, and performance metrics.
• To highlight current opportunities and challenges in phage display for therapeutic antibody development.

Main Methods:

• Comparative analysis of nine published phage display antibody libraries from the last decade.
• Evaluation of antibody repertoires (naïve, synthetic, semisynthetic).
• Review of library performance: positive clones per panning, hit rate, affinity, and developability.

Main Results:

• Analysis of library quality and diversity of antibody repertoires used.
• Performance metrics including hit rates and antibody affinity are compared.
• Selected antibodies' developability for therapeutic applications is assessed.

Conclusions:

• Phage display remains a powerful platform for discovering and optimizing therapeutic antibodies.
• Library design and repertoire choice significantly impact discovery success.
• Ongoing advancements and challenges exist for phage display and related technologies.